Add to ORKGanaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial shorter prophylaxis. Pregnant womenwith pre-existing anaemia and advanced HIV disease require closemonitoring. Sartorius et al. BMC Infectious Diseases 2013, 13:52
OBJECTIVE To evaluate the effect of routine antenatal haematinic supplementation programmes and inte...
Anaemia is associated with adverse outcomes including early death in the first year of antiretrovira...
Anemia is defined as a decrease in number of red blood cells (RBCs) or less than the normal quantity...
Background: Although substantiated by little evidence, concerns about zidovudine-related anaemia in ...
Background: Although substantiated by little evidence, concerns about zidovudine-related anaemia in ...
Anaemia is a common clinical finding in HIV infected women and has been associated with advanced dis...
BACKGROUND: Anaemia is a common clinical finding in HIV infected women and has been associated with ...
Background: Zidovudine (AZT) is a common component of antiretroviral therapy (ART) in resource-limit...
Background: HIV-infected pregnant women are particularly more susceptible to the deleterious effects...
OBJECTIVE: To describe the prevalence, incidence and predictors of severe anaemia in previously untr...
OBJECTIVE: Although zidovudine-free regimens are increasingly used in pregnancy, their haematologica...
BACKGROUND:The objective was to examine the short-term risk and predictors of anaemia following init...
Anemia is a major public health problem in Africa affecting over 80% of women in many countries. It ...
Anaemia is associated with adverse outcomes including early death in the first year of antiretrovira...
ObjectiveAntenatal anaemia is associated with increased peripartum transfusion requirement in South ...
OBJECTIVE To evaluate the effect of routine antenatal haematinic supplementation programmes and inte...
Anaemia is associated with adverse outcomes including early death in the first year of antiretrovira...
Anemia is defined as a decrease in number of red blood cells (RBCs) or less than the normal quantity...
Background: Although substantiated by little evidence, concerns about zidovudine-related anaemia in ...
Background: Although substantiated by little evidence, concerns about zidovudine-related anaemia in ...
Anaemia is a common clinical finding in HIV infected women and has been associated with advanced dis...
BACKGROUND: Anaemia is a common clinical finding in HIV infected women and has been associated with ...
Background: Zidovudine (AZT) is a common component of antiretroviral therapy (ART) in resource-limit...
Background: HIV-infected pregnant women are particularly more susceptible to the deleterious effects...
OBJECTIVE: To describe the prevalence, incidence and predictors of severe anaemia in previously untr...
OBJECTIVE: Although zidovudine-free regimens are increasingly used in pregnancy, their haematologica...
BACKGROUND:The objective was to examine the short-term risk and predictors of anaemia following init...
Anemia is a major public health problem in Africa affecting over 80% of women in many countries. It ...
Anaemia is associated with adverse outcomes including early death in the first year of antiretrovira...
ObjectiveAntenatal anaemia is associated with increased peripartum transfusion requirement in South ...
OBJECTIVE To evaluate the effect of routine antenatal haematinic supplementation programmes and inte...
Anaemia is associated with adverse outcomes including early death in the first year of antiretrovira...
Anemia is defined as a decrease in number of red blood cells (RBCs) or less than the normal quantity...